| Ticker Details |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$14.84B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.84 | 1.92%
|
| Avg Daily Range (30 D): |
$3.86 | 1.69%
|
| Avg Daily Range (90 D): |
$4.26 | 1.94%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.53M |
| Avg Daily Volume (90 D): |
.6M |
| Trade Size |
| Avg Trade Size (Sh.): |
67 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
57 |
| Institutional Trades |
| Total Institutional Trades: |
4,116 |
| Avg Institutional Trade: |
$3.78M |
| Avg Institutional Trade (30 D): |
$5.95M |
| Avg Institutional Trade (90 D): |
$7.17M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.91M |
| Avg Closing Trade (30 D): |
$7.48M |
| Avg Closing Trade (90 D): |
$9.34M |
| Avg Closing Volume: |
26.64K |
|
|
|
|
|
